| Item Type | Name |
|
Concept
|
Adenocarcinoma
|
|
Academic Article
|
Adjuvant therapy for pancreatic adenocarcinoma: what have we learned since 1985?
|
|
Academic Article
|
Combined modality adjuvant therapy for resected periampullary pancreatic and nonpancreatic adenocarcinoma: a review of studies and experience at The Johns Hopkins Hospital, 1991-2003.
|
|
Academic Article
|
Radiochemotherapy in the management of pancreatic cancer--part II: use in adjuvant and locally unresectable settings.
|
|
Academic Article
|
Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma--part 3: update on 5-year survival.
|
|
Academic Article
|
Radiotherapy in the adjuvant management of pancreatic adenocarcinoma.
|
|
Academic Article
|
Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct.
|
|
Academic Article
|
Adjuvant concurrent chemoradiation for node-positive adenocarcinoma of the duodenum.
|
|
Academic Article
|
Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial.
|
|
Academic Article
|
Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital.
|
|
Academic Article
|
Management of a patient with borderline resectable pancreatic cancer. Case report and review.
|
|
Academic Article
|
Standardization of surgical and pathologic variables is needed in multicenter trials of adjuvant therapy for pancreatic cancer: results from the ACOSOG Z5031 trial.
|
|
Academic Article
|
A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activation.
|
|
Academic Article
|
Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas.
|
|
Academic Article
|
Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial.
|
|
Academic Article
|
Supportive care considerations during concurrent chemoradiotherapy for pancreatic adenocarcinoma: lessons learned from clinical experience.
|
|
Academic Article
|
Radiotherapy in the adjuvant management of pancreatic adenocarcinoma: is it helpful?
|
|
Academic Article
|
A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer.
|
|
Academic Article
|
Evolving concepts regarding the use of radiotherapy in the adjuvant management of periampullary pancreatic adenocarcinoma.
|
|
Academic Article
|
Prognostic significance of carbohydrate antigen 19-9 in unresectable locally advanced pancreatic cancer treated with dose-escalated intensity modulated radiation therapy and concurrent full-dose gemcitabine: analysis of a prospective phase 1/2 dose escalation study.
|
|
Academic Article
|
Glycogen Synthase Kinase 3 Beta Predicts Survival in Resected Adenocarcinoma of the Pancreas.
|
|
Academic Article
|
RECQ1 A159C Polymorphism Is Associated With Overall Survival of Patients With Resected Pancreatic Cancer: A Replication Study in NRG Oncology Radiation Therapy Oncology Group 9704.
|
|
Academic Article
|
Standard vs. radical pancreaticoduodenectomy for periampullary adenocarcinoma: a prospective, randomized trial evaluating quality of life in pancreaticoduodenectomy survivors.
|
|
Academic Article
|
Cisplatin and etoposide before definitive radiation therapy for inoperable squamous carcinoma, adenocarcinoma, and large cell carcinoma of the lung: a phase I-II study of the Radiation Therapy Oncology Group.
|
|
Academic Article
|
Adjuvant therapy with chemotherapy and radiation therapy in the management of carcinoma of the pancreatic head.
|
|
Academic Article
|
Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group.
|
|
Academic Article
|
Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil/leucovorin infusion after pancreaticoduodenectomy.
|
|
Academic Article
|
Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer?
|
|
Academic Article
|
p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610.
|
|
Academic Article
|
Recurrent pancreatic adenocarcinoma: spiral CT evaluation following the Whipple procedure.
|
|
Academic Article
|
Intensive chemoradiation followed by esophagectomy for squamous cell and adenocarcinoma of the esophagus.
|
|
Academic Article
|
Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.
|
|
Academic Article
|
Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes.
|
|
Academic Article
|
A phase I clinical trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene for the treatment of pancreatic adenocarcinoma.
|
|
Academic Article
|
Should pancreaticoduodenectomy be performed in octogenarians?
|
|
Academic Article
|
Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels.
|
|
Academic Article
|
Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.
|
|
Academic Article
|
Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation.
|
|
Academic Article
|
Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.
|
|
Academic Article
|
Adjuvant therapy for pancreatic adenocarcinoma.
|
|
Academic Article
|
The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma.
|
|
Academic Article
|
Phase II study of external irradiation and weekly paclitaxel for nonmetastatic, unresectable pancreatic cancer: RTOG-98-12.
|
|
Academic Article
|
ACR Appropriateness Criteria? Resectable Pancreatic Cancer.
|
|
Academic Article
|
Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question-Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical Trial.
|